| Literature DB >> 33907457 |
Linjia Wang1, Zihan Yin1, Yutong Zhang1, Mingsheng Sun1, Yang Yu1, Yanming Lin2, Ling Zhao1.
Abstract
BACKGROUND: Nonspecific low back pain (NLBP) is a common disabling disease that cannot be attributed to a specific, recognizable pathology. The use of acupuncture for NLBP is supported by several guidelines and systematic reviews. However, the efficacy of different acupuncture methods for NLBP management is still debated. This study ranked the effectiveness of acupuncture methods using network meta-analysis to screen out the optimal acupuncture methods and expound the current controversies for their effective application in health policies as well as guiding clinical operations.Entities:
Keywords: acupuncture; network meta-analysis; nonspecific low back pain
Year: 2021 PMID: 33907457 PMCID: PMC8068518 DOI: 10.2147/JPR.S310385
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Search Strategy (PubMed)
| Steps | Search |
|---|---|
| #1 | “low back pain”[MeSH] OR “lumbago”[Ti/Ab] OR “low back ache”[Ti/Ab] |
| #2 | “acupuncture”[MeSH] OR “moxibustion” [MeSH] OR “electroacupuncture”[Ti/Ab] OR “electric acupuncture”[Ti/Ab] OR “fire needle”[Ti/Ab] OR “fire acupuncture”[Ti/Ab] OR “warm acupuncture”[Ti/Ab] OR “warm needle”[Ti/Ab] OR “needle warming moxibustion”[Ti/Ab] OR “heat sensitive moxibustion”[Ti/Ab] OR “auricular needle”[Ti/Ab] OR “ear needle”[Ti/Ab] OR “acupoint”[Ti/Ab] |
| #3 | “randomized controlled trial”[Pt] OR “controlled clinical trial”[Pt] OR “randomized”[Ti/Ab] OR “clinical trials as topic”[MeSH] OR “randomly”[Ti/Ab] OR “trial”[Ti] OR “clinical”[Ti] |
| #4 | English[Lan] |
| #5 | #1 AND #2 AND #3 AND #4 |
Figure 1Flow chart of study selection.
Figure 2Risk of bias graph.
Figure 3Risk of bias summary.
Pairwise Meta-Analysis of Reduction in VAS Score
| Comparison | Number | SMD (95% CI) | I2 (%) | p |
|---|---|---|---|---|
| A vs B | 4 | −0.17(−1.25,0.91) | 93 | <0.00001 |
| A vs D | 2 | 0 | 0.51 | |
| A vs E | 4 | 0.24(−0.42,0.89) | 83 | 0.0006 |
| A vs F | 3 | 0 | 0.39 | |
| A vs I | 1 | – | – | |
| A vs M | 1 | – | – | |
| A vs N | 2 | −0.31(−0.68,0.06) | 0 | 0.87 |
| A vs O | 2 | 0 | 0.92 | |
| B vs D | 1 | – | – | |
| B vs E | 1 | 0.63(−0.39,1.64) | – | – |
| B vs G | 1 | −0.59(−1.21,0.03) | – | – |
| B vs L | 1 | – | – | |
| C vs D | 2 | 80 | 0.03 | |
| C vs F | 1 | – | – | |
| D vs F | 1 | 0.10(−1.03,1.24) | – | – |
| D vs I | 1 | – | – | |
| D vs J | 1 | – | – | |
| D vs N | 1 | −1.13(−2.28,0.03) | – | – |
| D vs O | 1 | – | – | |
| E vs F | 1 | – | – | |
| E vs H | 1 | – | – | |
| F vs K | 1 | – | – | |
| F vs N | 1 | −1.18(−2.39,0.04) | – | – |
| G vs L | 1 | – | – | |
| G vs M | 1 | – | – |
Notes: The bold font indicates a statistical difference. A = manual acupuncture; B = electroacupuncture; C = moxibustion; D = conventional medicines; E = placebo; F = routine care; G = warm acupuncture; H = auricular needling; I = fire acupuncture; J = electroacupuncture plus conventional medicines; K = electroacupuncture plus moxibustion; L = electroacupuncture plus warm acupuncture; M = manual acupuncture plus moxibustion; N = manual acupuncture plus conventional medicines; O = fire acupuncture plus manual acupuncture.
Pairwise Meta-Analysis for Reduction in ODI Score
| Comparison | Number | SMD (95% CI) | I2 (%) | p |
|---|---|---|---|---|
| A vs B | 1 | / | / | |
| A vs D | 1 | 0.06(−0.47,0.58) | / | / |
| A vs E | 1 | 0.40(−0.16,0.96) | / | / |
| A vs F | 3 | 0.32(−0.13,0.77) | 68 | 0.04 |
| A vs M | 1 | / | / | |
| A vs N | 1 | / | / | |
| B vs D | 1 | / | / | |
| C vs F | 1 | / | / | |
| D vs I | 1 | / | / | |
| E vs F | 1 | 0.47(−0.09,1.04) | / | / |
| F vs K | 1 | / | / | |
| G vs M | 1 | / | / |
Notes: The bold font indicates a statistical difference. A = manual acupuncture; B = electroacupuncture; C = moxibustion; D = conventional medicines; E = placebo; F = routine care; G = warm acupuncture; I = fire acupuncture; K = electroacupuncture plus moxibustion; M = manual acupuncture plus moxibustion; N = manual acupuncture plus conventional medicines.
Figure 4Network plot of VAS scores.
Figure 5Network plot of ODI scores.
Figure 6Network meta-analysis results for VAS and ODI scores.
Figure 7Ranking probability figure for reduction in VAS score.
Figure 8Ranking probability figure for reduction in ODI score.
Figure 9Cluster ranking plot based on reduction in VAS and ODI scores.
Figure 10Number of AEs for different treatment measures.
Figure 11Funnel plot for the network meta-analysis of reduction in VAS score.
Figure 12Funnel plot for the network meta-analysis of reduction in ODI score.